to obtain the eggs. Fertilisation was successful in 40 eggs. These had to be implanted into another 20 females. The result was just one monkey bearing a marker gene. It can be assumed that many more animals would be required in order to obtain one animal carrying a disease gene which had integrated in the right place to provide an adequate disease model.
The welfare costs and the large numbers of animals involved in transgenic production are all the more problematical where monkeys are concerned. They are longer-lived, of higher evolutionary development, and of a higher degree of awareness than rodents. Any concerns that have been expressed so far with reference to transgenic rodents are multiplied manyfold when applied to transgenic monkeys.
The number of animals required to produce just one transgenic monkey, and the complexity of the procedures involved, inevitably mean that transgenic monkeys will be phenomenally expensive. This, together with the specialised accommodation and care required for laboratory primates, makes it unlikely that we will see a huge explosion in primate use paralleling the 960% increase in the use of transgenic rodents that occurred during in the UK 1990-1999. On the other hand, the expense involved could well mean than scientists will use minimal numbers of these animals in their studies. As a result, the data obtained may be difficult to interpret and may not be amenable to statistical analysis. This has already been noted as a problem in some areas of primate research, and will clearly apply even more to work with transgenic primates.
In conclusion, whereas ANDi may represent a triumph of science and technique for his creators, he also raises many concerns, particularly among those who wish to see a rapid end to all use of laboratory primates.
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